Evidence map›Paper›PMID 28470428›Full record

ArticleClinical rheumatology2017

Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis.

Like Zhao, Qian Wang, Chunmei Zhang, Cibo Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Epigenetics as a Therapeutic Target in Osteoarthritis.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Acteoside Counteracts Interleukin-1Oxidative medicine and cellular longevity · 2021
    Article
  10. Article
  11. Epigenetic Therapies for Osteoarthritis.Trends in pharmacological sciences · 2020
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Abnormal DNA Methylation in Thoracic Spinal Cord Tissue Following Transection Injury.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Like ZhaoDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, No. 1 Da Hua Road, Dong Dan, Beijing, 100730, People's Republic of China. likezhao@126.com.
Qian WangDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, No. 1 Da Hua Road, Dong Dan, Beijing, 100730, People's Republic of China.
Chunmei ZhangDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, No. 1 Da Hua Road, Dong Dan, Beijing, 100730, People's Republic of China.
Cibo HuangDepartment of Rheumatology, Beijing Hospital, National Center of Gerontology, No. 1 Da Hua Road, Dong Dan, Beijing, 100730, People's Republic of China.
Beijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study is to identify osteoarthritis (OA)-associated differentially methylated genes in human articular chondrocytes from patients with OA. DNA methylation profiling of articular chondrocytes from OA patients, rheumatoid arthritis (RA) patients, and controls was performed, and candidate genes were chosen for validation of gene demethylation status. The mRNA expression levels of candidate genes in chondrocytes were detected by real-time quantitative PCR. Chondrocytes from OA and RA group were treated with 5-Aza-2-deoxycytidine (5-Aza), and then the mRNA expression levels were detected. Forty-five genes with significant methylation differences between OA and control group were identified. Tumor necrosis factor receptor-associated factor 1 (TRAF1), connective tissue growth factor (CTGF), and chemokine (C-X3-C motif) ligand 1(CX3CL1) genes were hypomethylated in chondrocytes of OA and RA patients, which verified by bisulfite sequencing analysis. The mRNA expression level of TRAF1 and CTGF was significantly increased in OA and RA group (p < 0.05), while the expression level of CX3CL1 was only increased in OA group (p < 0.05). For the chondrocytes from OA and RA treated with 5-Aza, the mRNA expression level of TRAF1 and CTGF was highly increased (p < 0.05). It is the first time to show that TRAF1, CTGF, and CX3CL1 genes were hypomethylated in OA chondrocytes and have a consistent correlation with mRNA expression, which suggests that epigenetic changes in the methylation status of TRAF1, CTGF, and CX3CL1 contribute to the pathology of OA.

Indexed as

DNA MethylationAgedAged, 80 and overArthritis, RheumatoidAzacitidineCartilage, ArticularCells, CulturedChemokine CX3CL1ChondrocytesConnective Tissue Growth FactorDecitabineEpigenesis, GeneticFemaleHumansLigandsMaleAzacitidineCCN2 protein, humanChemokine CX3CL1Connective Tissue Growth FactorCX3CL1 protein, humanDecitabineLigandsRNA, MessengerTNF Receptor-Associated Factor 1ChondrocytesMethylationOsteoarthritis

Identifiers

PMID28470428
OpenAlexW2610466042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.